focus -WSS

focus

author：knowledge 2025-09-27 13:04:51 - browse：8

ADAM FEUERSTEIN/STAT

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up here.

CHICAGO — It’s only Day 2, but the ASCO meeting is already in full force. That means hordes of oncologists filling the halls, reams of data streaming through the meeting, and incredibly long lines for even the worst food. And STAT reporters Angus Chen, Adam Feuerstein, and Matthew Herper are in the thick of it – on the heels of STAT’s own in-person event here, which was standing room only and came with its own share of thrills, chills, and not a little bit of audience laughter. More on that in a bit.

Here’s a rundown of some of the big news from the first 24 hours of the meeting which, due to some weird kind of relativistic time dilation, represents about a week for our intrepid reporters.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Videos point to link between seizures and unexplained toddler deaths

WSS

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Why Titanic fascinates society, still drawing tours to the wreckage

J&J to buy cancer drug developer Ambrx Biopharma

Feng Zhang, Grail founder join forces on new gene editing startup

How a scoliosis diagnosis changed the life of one young dancer

Burning questions for the 2024 JPM Healthcare Conference

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Hepatitis C has a cure — but many Americans still lack access to it

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Another man arrested in connection with shooting at Kansas nightclub

How to save PrEP access — and even expand it

North Korean leader's powerful sister says warplanes repelled US spy plane

Walensky prepares to leave CDC — and Congress — behind

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

explore

Rare Northern Lights show in US this week: Where and how to see it

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

New weight loss drugs work. But how can they best be used?

House panel to mark up pandemic

explore

hotspot

knowledge

hotspot